Valneva in talks with EU about 60 million vaccine doses
French Valneva SE announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.
Immunocore bags US$75m in Series C round
Immuno-oncology specialist Immunocore plc announced the completion of a $75m Series C private financing round.
EU approves second COVID-19 vaccine
Following a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.
Angelini Pharma to take over Arvelle Therapeutics
Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.
COVID-19 test gives results within minutes
University of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results.
EMA greenlights BioNtech’s COVID-19 vaccine
Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally approve BioNTechs mRNA vaccine BNT162b2 in the EU.
European Circular Bioeconomy Fund growing
Only two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.
Novo Holdings creates Hemab
Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.
Biotech companies launch Biotech Austria
Austria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.
How microplastic particles get into the body
Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.